Navigating the evolving landscape of HFpEF management: A detailed look at key ACC/AHA/ESC guideline updates

Niyati Grewal; Jaspreet Singh Grewal; Mohammed Aldhaeefi; Prafulla P Mehrotra; Urooj Fatima

doi:10.1016/j.carrev.2024.04.004

Navigating the evolving landscape of HFpEF management: A detailed look at key ACC/AHA/ESC guideline updates

Cardiovasc Revasc Med. 2024 Apr 4:S1553-8389(24)00148-9. doi: 10.1016/j.carrev.2024.04.004. Online ahead of print.

Authors

Niyati Grewal¹, Jaspreet Singh Grewal², Mohammed Aldhaeefi³, Prafulla P Mehrotra⁴, Urooj Fatima⁵

Affiliations

¹ Department of Internal Medicine, Howard University Hospital, USA. Electronic address: niyatigrewal@gmail.com.
² Department of Medicine, Manipal College of Medical Sciences, Nepal.
³ Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, DC, USA. Electronic address: mohammed.aldhaeefi@howard.edu.
⁴ Department of Cardiology, Howard University Hospital, USA. Electronic address: pmehrotra@howard.edu.
⁵ Department of Cardiology, Howard University Hospital, USA. Electronic address: ufatima@huhosp.org.

PMID: 38664130
DOI: 10.1016/j.carrev.2024.04.004

Abstract

Heart failure, a growing concern in the United States, significantly impacts both morbidity and mortality. Classified by ejection fraction, heart failure with preserved ejection fraction (HFpEF) now accounts for half of all cases and is steadily rising. Unlike its counterpart, heart failure with reduced ejection fraction (HFrEF), HFpEF lacks clear management guidelines. Recognizing this critical gap, we aim to review existing recommendations and formulate effective management strategies for HFpEF.

Keywords: Cardiomyopathy; Cardiovascular care; Heart failure; Integrated review; Ventricular dysfunction.

Publication types

Review